Windlas Biotech Ltd. | Small-cap | Healthcare
₹892.30
-0.31%
| Windlas Biotech Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 7.6B
Gross Profit 2.9B 37.90%
Operating Income 661.2M 8.70%
Net Income 609.9M 8.03%

Balance Sheet Metrics

Total Assets 7.6B
Total Liabilities 2.5B
Shareholders Equity 5.1B
Debt to Equity 0.50

Cash Flow Metrics

Operating Cash Flow 396.8M
Free Cash Flow 159.9M

Revenue & Profitability Trend

Windlas Biotech Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 7.6B 6.3B 5.1B 4.6B 4.3B
Cost of Goods Sold 4.7B 4.0B 3.3B 3.0B 2.7B
Gross Profit 2.9B 2.3B 1.9B 1.6B 1.5B
Operating Expenses 710.0M 685.7M 564.7M 463.3M 374.9M
Operating Income 661.2M 647.3M 479.2M 405.9M 443.3M
Pre-tax Income 797.6M 770.9M 570.4M 455.6M 217.4M
Income Tax 187.6M 189.0M 144.1M 74.8M 61.7M
Net Income 609.9M 581.9M 426.3M 380.9M 155.7M
EPS (Diluted) - ₹27.88 ₹19.70 ₹18.58 ₹4.86

Income Statement Trend

Windlas Biotech Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 5.3B 4.3B 3.5B 3.8B 1.9B
Non-Current Assets 2.4B 1.9B 1.8B 1.1B 1.0B
Total Assets 7.6B 6.3B 5.3B 4.9B 3.0B
Liabilities
Current Liabilities 2.5B 1.7B 1.2B 939.9M 934.2M
Non-Current Liabilities 52.4M 45.2M 54.6M 22.5M 35.8M
Total Liabilities 2.5B 1.8B 1.3B 962.3M 970.0M
Equity
Total Shareholders Equity 5.1B 4.5B 4.0B 3.9B 2.0B

Balance Sheet Composition

Windlas Biotech Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 797.6M 770.9M 570.4M 455.6M 217.4M
Operating Cash Flow 396.8M 779.8M 366.4M -162.9M 278.6M
Investing Activities
Capital Expenditures -520.0M -376.4M -699.8M -146.9M -58.3M
Investing Cash Flow -520.0M -376.4M -699.8M -146.9M -218.6M
Financing Activities
Dividends Paid -115.0M -83.0M -76.3M - -
Financing Cash Flow 199.4M -126.6M -405.0M 1.4B 38.8M
Free Cash Flow 159.9M 712.8M -99.2M -56.7M 56.1M

Cash Flow Trend

Windlas Biotech Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 31.43
Price to Book 3.76
Price to Sales 2.50

Profitability Ratios

Profit Margin 8.03%
Operating Margin 10.67%
Return on Equity 12.76%
Return on Assets 5.96%

Financial Health

Current Ratio 2.10
Debt to Equity 6.45
Beta 0.31

Per Share Data

EPS (TTM) ₹28.86
Book Value per Share ₹241.38
Revenue per Share ₹363.66

Financial data is updated regularly. All figures are in the company's reporting currency.